Oxford/AstraZeneca vaccine 80 per cent effective against B1.617.2 variant: UK study

According to The Telegraph' newspaper, the latest study's findings were presented to a meeting of the government's New and Emerging Respiratory Virus Threats Advisory Group (Nervtag) this week.

from Lifestyle News:Entertainment News,Bollywood Latest News,Box Office Collection Report,Movie Reviews
Read The Rest:financialexpress...